Scientific Conferences for The College on Problems of Drug Dependence (CPDD)

摘要 这是一项申请，要求将R13DA013192补助金续期5年，以继续支持以下项目的旅行奖励 学员和早期职业研究人员将出席学院药物问题年会 依赖(CPDD)。CPDD是致力于物质使用研究的最古老的科学协会。AS 唯一一次将研究各个方面的研究人员聚集在一起的年度国内或国际会议 和药物使用问题的方法，CPDD的会议提供了一个特别的 为实习生和该领域的早期职业研究人员提供丰富的经验。这次会议吸引了基本的 和来自全美和大约40个国家的临床研究人员，在职业生涯的各个阶段 从博士生到高级调查人员，以及来自政府和 工业。它包括科学家、医生、护士、临床心理学家、管理人员、政策制定者、 从事物质使用研究或对物质使用研究感兴趣的记者和其他人。我们的会议是一个论坛， 来自广泛学科的研究人员(例如，药物化学、分子生物学、 药理学、遗传学、神经影像学、心理学、社会学、成瘾医学、公共卫生、 流行病学)以正式和非正式的形式分享他们的最新发现、建立网络并相互学习 交流。我们预计在我们未来的每一次会议上都会有1000-1300名与会者，这是由 相互竞争的更新。在下一个资助期，我们建议继续支持以下项目的旅行奖励 参加国家发改委年会的受训人员和职业初期研究人员。在会议上讨论的主题 应对变化，关注新出现的问题和该领域的前沿研究，每年 与NIDA的主要计划领域(例如流行病学、预防、卫生)高度相关的会议 服务、药物开发、神经科学、行为学、艾滋病毒/艾滋病和健康差距) 包括在内。介绍了各种滥用药物，包括阿片类药物、兴奋剂、镇静剂、 大麻、迷幻剂、尼古丁和酒精。会议包括颁奖、讲座和论坛 政策、动物和人类研究、工业界/学术界/政府合作和媒体宣传， 以及针对受训者、早期职业研究人员、代表不足的少数群体的活动 和国际科学家。我们希望我们的年度会议能够加速物质使用方面的创新 通过我们内容的翻译性和通过建立的协作进行研究 在代表会议的各个学科的与会者之间进行交流。我们还期待着调查结果 由于我们的媒体外展活动和新的 开发了虚拟产品，可以显著改善对药物使用的预防和治疗 在与物质使用有关的情况下，向政策提供信息。

ABSTRACT This is a request for a 5-year renewal of grant R13DA013192 to continue to support travel awards for trainees and early career researchers to attend annual meetings of the College on Problems of Drug Dependence (CPDD). CPDD is the oldest scientific society dedicated to substance use research. As the only annual national or international meeting that brings together researchers studying all aspects and approaches to the problems of substance use, CPDD’s conference provides a particularly enriching experience for trainees and early career researchers in the field. The meeting attracts basic and clinical researchers from throughout the United States and about 40 countries, at all career stages from predoctoral students through senior investigators, as well as representatives from government and industry. It includes scientists, physicians, nurses, clinical psychologists, administrators, policy makers, journalists and others working on or interested in substance use research. Our meetings are a forum for researchers from a broad range of disciplines (e.g., medicinal chemistry, molecular biology, pharmacology, genetics, neuroimaging, psychology, sociology, addiction medicine, public health, epidemiology) to share their recent findings, network and learn from one another in formal and informal exchanges. We expect 1000-1300 attendees at each of our future meetings supported by this competing renewal. In the next funding period, we propose to continue to support travel awards for trainees and early career researchers to attend the CPDD annual meetings. Topics addressed at the meeting change with emerging concerns and cutting-edge research in the field, and, each year, sessions highly relevant to NIDA's major program areas (e.g., epidemiology, prevention, health services, medications development, neuroscience, behavior, HIV/AIDS and health disparities) are included. Presentations span the full range of drugs of abuse, including opioids, stimulants, sedatives, cannabis, hallucinogens, nicotine and alcohol. The conference includes awards lectures and forums on policy, animal and human research, industry/academia/government collaboration and media outreach, as well as activities directed towards trainees, early career researchers, underrepresented minorities and international scientists. We expect our annual meetings to accelerate innovation in substance use research through the translational nature of our content and through the collaborations that are built between attendees across the disciplines represented at the meeting. We also expect findings presented at the meeting to reach a broader audience due to our media outreach activities and newly developed virtual offerings, which can significantly improve prevention and treatment of substance use disorders and inform policy as it relates to substance use.